Fundz

Adbiotech buys 51% of Bestee's Korean unit

PRIVATENov 19, 2026

Acquiring Company

AD Biotech

Acquired Company

Bestee's Korean distribution company

AlmatySouth KoreaBiotechnologyE CommerceFashionBeautyCosmetics

Description

Adbiotech said on November 19 that it acquired a 51% stake in the Korean distribution company of Kazakhstan-based K-beauty platform Bestee. The deal follows a business partnership announced last October and gives Adbiotech direct control over Korean cosmetics sourcing and export operations. Adbiotech plans to use Bestee's local distribution and influencer network to expand into Central Asia, starting with Kazakhstan.

Quick answer

AD Biotech is acquiring Bestee's Korean distribution company, announced November 19, 2026. AD Biotech is based in Almaty, Almaty Region, Kazakhstan.

How much did AD Biotech pay for Bestee's Korean distribution company?
The deal value was not disclosed.
What does AD Biotech do?
AD Biotech is a company focused on expanding Korean beauty products in international markets.
Where are AD Biotech and Bestee's Korean distribution company based?
AD Biotech is based in Almaty, Almaty Region, Kazakhstan. Bestee's Korean distribution company is based in South Korea.

Source: Fundz verified event record.

Other recent acquisitions in E Commerce and Fashion

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at AD Biotech, and when

When AD Biotech changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day AD Biotech raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at AD Biotech, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at AD Biotech. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

AD Biotech

Location

Almaty, Almaty Region, Kazakhstan

About

AD Biotech is a company focused on expanding Korean beauty products in international markets. They specialize in identifying competitive cosmetics brands and developing partnerships to enhance distribution strategies. The company is keen on entering new markets and leveraging local consumer insights. AD Biotech aims to strengthen its presence in Central Asia through innovative collaborations.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment AD Biotech makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for AD Biotech's next move

Learn about Strategic plan

Frequently asked

Who acquired Bestee's Korean distribution company?

Bestee's Korean distribution company was acquired by AD Biotech, based in Almaty. The deal was reported on November 19, 2026. AD Biotech is a company focused on expanding Korean beauty products in international markets. They specialize in identifying competitive cosmetics brands and developing partnerships to enhance distribution strategies. AD Biotech is privately held and operates in Biotechnology.

When did AD Biotech acquire Bestee's Korean distribution company?

AD Biotech's acquisition of Bestee's Korean distribution company was reported on November 19, 2026. Adbiotech said on November 19 that it acquired a 51% stake in the Korean distribution company of Kazakhstan-based K-beauty platform Bestee. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Bestee's Korean distribution company do?

The Korean distribution company is the Korean arm of Bestee, a Kazakhstan-based K-beauty platform. It handles the discovery of Korean cosmetics brands, product sourcing, and exports to Central Asia. It is privately held, operating in E Commerce, and is based in South Korea.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.